Remifentanil-based analgesia and sedation is well tolerated when administered for up to 10 days in mechanically ventilated ICU patients
A Karabinis et al
Critical Care
Springer Nature
Mar 15, 2004
Copyright © 2004, BioMed Central Ltd.
Welcome to RightsLink
Springer Nature has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing this content.
I would like to...This drop down menu contains the options the publisher has agreed to permit for reuse of their copyrighted material. The publisher offers these types of use either directly through RightsLink or after approval by the publisher. Please reference the terms and conditions offered during the order process for a complete understanding of the use you select. Need more info?
To request permission for a type of use not listed, please contact Springer Nature